Brideau-Andersen; Amy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brideau-Andersen; Amy.The latest application filed is for "combination therapy using clostridial toxin derivative and at least one chemical depolarizing agent".

Company Profile

5.3.9

Brideau-Andersen; Amy - San Clemente CA
Brideau-Andersen; Amy - Irvine CA
BRIDEAU-ANDERSEN; Amy - Irivine CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy Using Clostridial Toxin Derivative And At Least One Chemical Depolarizing Agent App 20220096609 - Dolly; James Oliver ; et al.	2022-03-31
Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation Grant 11,149,262 - Jacky , et al. October 19, 2	2021-10-19
Botulinum Toxin Cell Binding Domain Polypeptides And Methods Of Use For Treatments Of Fibrosis Associated Disorders App 20210277377 - Jacky; Birgitte PS ; et al.	2021-09-09
Botulinum Neurotoxin For Treatment Of Disorders Associated With Melanocyte Hyperactivity And/or Excess Melanin App 20210162027 - Jacky; Birgitte P.S. ; et al.	2021-06-03
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin Grant 10,912,823 - Jacky , et al. February 9, 2	2021-02-09
Method For Delivery Of Biologic Agents From A Topical Formulation App 20190343759 - Steward; Lance ; et al.	2019-11-14
Botulinum Toxin Cell Binding Domain Polypeptides And Methods Of Use For Treatments Of Fibrosis Associated Disorders App 20190185837 - Jacky; Birgitte PS ; et al.	2019-06-20
Botulinum Toxin Cell Binding Domain Polypeptides And Methods Of Use For Skin Rejuvenation App 20190185523 - Jacky; Birgitte PS ; et al.	2019-06-20
Botulinum Neurotoxin For Treatment Of Disorders Associated With Melanocyte Hyperactivity And/or Excess Melanin App 20180344820 - Jacky; Birgitte P.S. ; et al.	2018-12-06
Polypeptide Inhibitors Of Vla4 App 20120135912 - PAIDHUNGAT; MADAN M. ; et al.	2012-05-31
Evolved interferon-alpha polypeptides Grant 7,619,067 - Paidhungat , et al. November 17, 2	2009-11-17
Evolved Interferon-alpha Polypeptides App 20080226597 - PAIDHUNGAT; Madan M. ; et al.	2008-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.